Product Information
NAMZARIC 21 MG-10 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $19.9565 per EA under NDC 00456122130. Its NADAC has been published 492 times since Mar 22, 2017.
FDA first approved this application on Dec 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 21 mg/1; mg/1
Manufacturer
Allergan, Inc.NDC
00456122130
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206439FDA Approved
12/23/2014
TE Code
AB
On Market Since
7/18/2016
Pharmacological Classes
Price Statistics
The NADAC for NAMZARIC 21 MG-10 MG CAPSULE has been published 492 times since Mar 22, 2017, and over the history we have for it it has risen 61.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.9565 per EA |
|---|---|
| All-time high | $19.9565 (Aug 19, 2026) |
| All-time low | $12.3324 (Mar 22, 2017) |
| 52-week high | $19.9565 |
| 52-week low | $19.7649 |
| Median price | $16.3258 |
| Average price | $16.5779 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 492 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the memantine hydrochloride and donepezil hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAMZARIC 21 MG-10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NAMZARIC 21 MG-10 MG CAPSULE, manufactured by Allergan, Inc., is $19.9565 per EA (NDC 00456122130), effective Aug 19, 2026.
How has the price of NAMZARIC 21 MG-10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NAMZARIC 21 MG-10 MG CAPSULE has risen 61.8%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for NAMZARIC 21 MG-10 MG CAPSULE?
Since Mar 22, 2017, the NADAC for NAMZARIC 21 MG-10 MG CAPSULE has ranged from a low of $12.3324 (Mar 22, 2017) to a high of $19.9565 (Aug 19, 2026), with a median of $16.3258 per EA.
Are there cheaper alternatives to NAMZARIC 21 MG-10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of NAMZARIC 21 MG-10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAMZARIC 21 MG-10 MG CAPSULE?
NAMZARIC 21 MG-10 MG CAPSULE (NDC 00456122130) is labeled by Allergan, Inc., and CMS classifies it as a brand product.